405 related articles for article (PubMed ID: 27084704)
1. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lee BB; Toh SL; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber G; Kaur J; Boswell-Ruys C; Goodall S; Middleton J; Tudehope M; Kotsiou G
BMC Urol; 2016 Apr; 16():18. PubMed ID: 27084704
[TBL] [Abstract][Full Text] [Related]
2. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Toh SL; Lee BB; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber GH; Kaur J; Boswell-Ruys CL; Goodall S; Middleton JW; Tuderhope M; Kotsiou G
Spinal Cord; 2019 Jul; 57(7):550-561. PubMed ID: 30814670
[TBL] [Abstract][Full Text] [Related]
3. Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial.
Toh SL; Lee BB; Simpson JM; Rice SA; Kotsiou G; Marial O; Ryan S
Spinal Cord; 2020 Jul; 58(7):755-767. PubMed ID: 31953482
[TBL] [Abstract][Full Text] [Related]
4. Probiotics for preventing urinary tract infection in people with neuropathic bladder.
Toh SL; Boswell-Ruys CL; Lee BSB; Simpson JM; Clezy KR
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010723. PubMed ID: 28884476
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.
Daniel M; Szymanik-Grzelak H; Turczyn A; Pańczyk-Tomaszewska M
BMC Urol; 2020 Oct; 20(1):168. PubMed ID: 33097017
[TBL] [Abstract][Full Text] [Related]
6. Intravesical
Groah SL; Tractenberg RE
Top Spinal Cord Inj Rehabil; 2022; 28(4):12-21. PubMed ID: 36457355
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Probiotic Prophylaxis After The First Febrile Urinary Tract Infection in Children With Normal Urinary Tracts.
Sadeghi-Bojd S; Naghshizadian R; Mazaheri M; Ghane Sharbaf F; Assadi F
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):305-310. PubMed ID: 31100124
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial.
Gupta V; Mastromarino P; Garg R
Clin Infect Dis; 2024 May; 78(5):1154-1161. PubMed ID: 38084984
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study.
Linsenmeyer TA; Harrison B; Oakley A; Kirshblum S; Stock JA; Millis SR
J Spinal Cord Med; 2004; 27(1):29-34. PubMed ID: 15156934
[TBL] [Abstract][Full Text] [Related]
10. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
Huen KH; Nik-Ahd F; Chen L; Lerman S; Singer J
J Pediatr Urol; 2019 Apr; 15(2):178.e1-178.e7. PubMed ID: 30611650
[TBL] [Abstract][Full Text] [Related]
11. Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT.
Pickard R; Chadwick T; Oluboyede Y; Brennand C; von Wilamowitz-Moellendorff A; McClurg D; Wilkinson J; Ternent L; Fisher H; Walton K; McColl E; Vale L; Wood R; Abdel-Fattah M; Hilton P; Fader M; Harrison S; Larcombe J; Little P; Timoney A; N'Dow J; Armstrong H; Morris N; Walker K; Thiruchelvam N
Health Technol Assess; 2018 May; 22(24):1-102. PubMed ID: 29766842
[TBL] [Abstract][Full Text] [Related]
12. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females.
Ng QX; Peters C; Venkatanarayanan N; Goh YY; Ho CYX; Yeo WS
Med Hypotheses; 2018 May; 114():49-54. PubMed ID: 29602464
[TBL] [Abstract][Full Text] [Related]
13. Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.
Wade D; Cooper J; Derry F; Taylor J
Trials; 2019 Apr; 20(1):223. PubMed ID: 30992071
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of
Groele L; Szajewska H; Szalecki M; Świderska J; Wysocka-Mincewicz M; Ochocińska A; Stelmaszczyk-Emmel A; Demkow U; Szypowska A
BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33771763
[TBL] [Abstract][Full Text] [Related]
15. Intravesical
Groah SL; Rounds AK; Pérez-Losada M
Top Spinal Cord Inj Rehabil; 2023; 29(3):44-57. PubMed ID: 38076286
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of oral intake of
Sharpe M; Shah V; Freire-Lizama T; Cates EC; McGrath K; David I; Cowan S; Letkeman J; Stewart-Wilson E
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1814-1821. PubMed ID: 31362572
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction.
Morton SC; Shekelle PG; Adams JL; Bennett C; Dobkin BH; Montgomerie J; Vickrey BG
Arch Phys Med Rehabil; 2002 Jan; 83(1):129-38. PubMed ID: 11782843
[TBL] [Abstract][Full Text] [Related]
18. Effects of Intravesical Lactobacillus Rhamnosus GG on Urinary Symptom Burden in People with Neurogenic Lower Urinary Tract Dysfunction.
Tractenberg RE; Groah SL; Frost JK; Rounds AK; Davis E; Ljungberg IH; Schladen MM
PM R; 2021 Jul; 13(7):695-706. PubMed ID: 32798286
[TBL] [Abstract][Full Text] [Related]
19. Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
Wolff BJ; Price TK; Joyce CJ; Wolfe AJ; Mueller ER
Int Urol Nephrol; 2019 Dec; 51(12):2149-2159. PubMed ID: 31535332
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation for primary prevention of urinary tract infections in patients with spinal cord injury during primary rehabilitation: protocol for a randomized placebo-controlled pilot trial (UROVAXOM-pilot).
Krebs J; Stoyanov J; Wöllner J; Valido E; Pannek J
Trials; 2021 Oct; 22(1):677. PubMed ID: 34607600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
